• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
CUE

CUE

Cue Biopharma, Inc.

NASDAQHealthcareBiotechnologyUS

USD26.91

-1.71 (-5.97%)

Rating:C

Company Profile

CEO

Lucinda Warren

IPO Date

2018-01-02

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$28.57

Prev. Close

$28.62

Day Low

$25.50

Day High

$29.25

52W Low

$4.98

52W High

$41.42

Market Cap

$0.07B

Volume

0.07M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

29.8%

Avg Negative

3.3%

Avg Neutral

67.0%

News Feed

Cue Biopharma, Inc. (CUE) CEO Dan Passeri on Q2 2021 Results - Earnings Call Transcript

Seeking Alpha·8/17/2021·↓ negative

Cue Biopharma Reports Second Quarter 2021 Results, Recent Data Updates of CUE-101 Phase 1 Dose Escalation and Expansion Study, Platform Progress and Business Highlights

GlobeNewsWire·8/17/2021·↑ positive

Cue Biopharma to Present Corporate Update at the Upcoming BTIG Virtual Biotechnology Conference

GlobeNewsWire·8/3/2021·↑ positive

Earnings Preview: Cue Biopharma, Inc. (CUE) Q2 Earnings Expected to Decline

Zacks Investment Research·7/30/2021·↑ positive

Cue Biopharma to Present at the Upcoming JMP Securities Life Sciences Conference

GlobeNewsWire·6/14/2021·↑ positive

Cue Biopharma to Present at the 2021 Federation of Clinical Immunology Societies (FOCIS) Virtual Annual Meeting

GlobeNewsWire·6/3/2021·↑ positive

Cue Biopharma, Inc. (CUE) CEO Daniel Passeri on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/17/2021·↓ negative

Strength Seen in Cue Biopharma, Inc. (CUE): Can Its 27.7% Jump Turn into More Strength?

Zacks Investment Research·5/11/2021·↑ positive

Cue Biopharma's Stock Shoots Up After CUE-101 Shows Promise In Early-Stage Head & Neck Cancer Study

Benzinga·5/10/2021·↑ positive

CUE Stock: Over 10% Increase Pre-Market Explanation

Pulse2·5/10/2021·↑ positive